Dapicub 500 mg Powder for solution for infusion
PDF Leaflet Revision Date: 14 March 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Complicated skin and skin structure infections and Staphylococcus aureus bloodstream infections.
Dosage (summary)
cSSTI: 4 mg/kg once daily for 7-14 days; SAB: 6 mg/kg once daily for 2-6 weeks.
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- Myopathy with HMG-CoA reductase inhibitors
- False PT/INR prolongation
- Caution with tobramycin
Contraindications
- Hypersensitivity to daptomycin
Common side effects
- Fungal infections
- Anemia
- Dizziness
- Nausea
- Rash
Counselling Points
- Monitor for muscle pain and CPK levels
- Avoid driving if dizziness occurs
- Report any signs of allergic reactions
Serious warnings
- Risk of Clostridium difficile-associated diarrhea
- Eosinophilic pneumonia
- Renal impairment
Important Disclaimer
The Dapicub 500 mg Powder for solution for infusion professional information leaflet below is the property of Kahma Biotech and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
